Ordering Moderna's Bivalent vaccine
From: Athina Andonatou
Dear Pharmaceutical Management Agency,
I wrote to MOH regarding Moderna's bivalent vaccine and was advised that it was your organization that from the 1st July 2022 would be responsible for vaccine purchases. https://fyi.org.nz/request/20257/respons...
So I will ask the same questions here:
Is Pharmac looking at purchasing COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a “bivalent” vaccine)? If yes, please provide me with the following documents:
1) How many doses have been ordered?
2) Cost per dose?
3) Criteria used to assess whether to purchase or not?
4) Scientific studies used to support purchase?
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora Athina,
Thank you for your email. Your request has been received and logged as of 16 September 2022. Our reference number for your request is 2022-23-035.
As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 14 October 2022.
If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.
Gendi McFadyen| Government Services Advisor
Te Pātaka Whaioranga | Pharmac
PO Box 10-254, Wellington 6140 | Level 9, 40 Mercer Street, Wellington 6011
P: 0800 660 050 | www.pharmac.govt.nz